In: Cellular and Molecular Life Sciences CMLS, 2006, vol. 63, no. 4, p. 449-468
|
In: Annals of Oncology, 2011, vol. 22, no. 2, p. 458-467
|
In: Annals of Oncology, 2009, vol. 21, no. 2, p. 245-254
|
In: Glycobiology, 2007, vol. 17, no. 2, p. 185-196
|
In: Human Reproduction, 2002, vol. 17, no. 6, p. 1610-1615
|
In: International Journal of Cancer, 2014, p. -
The p120 RasGAP protein negatively regulates Ras via its GAP domain. RasGAP carries several other domains that modulate several signaling molecules such as Rho. RasGAP is also a caspase-3 substrate. One of the caspase-3-generated RasGAP fragments, corresponding to amino acids 158–455 and called fragment N2, was previously reported to specifically sensitize cancer cells to death induced by...
|
In: Oncogene, 2012, vol. 31, p. 48-59
Cyclooxyganase-2 (COX-2), a rate-limiting enzyme in the prostaglandin synthesis pathway, is overexpressed in many cancers and contributes to cancer progression through tumor cell-autonomous and paracrine effects. Regular use of non-steroidal anti-inflammatory drugs or selective COX-2 inhibitors (COXIBs) reduces the risk of cancer development and progression, in particular of the colon. The COXIB...
|